290 related articles for article (PubMed ID: 33848536)
1. A Gut-Intrinsic Melanocortin Signaling Complex Augments L-Cell Secretion in Humans.
Sun EW; Iepsen EW; Pezos N; Lumsden AL; Martin AM; Schober G; Isaacs NJ; Rayner CK; Nguyen NQ; de Fontgalland D; Rabbitt P; Hollington P; Wattchow DA; Hansen T; Holm JC; Liou AP; Jackson VM; Torekov SS; Young RL; Keating DJ
Gastroenterology; 2021 Aug; 161(2):536-547.e2. PubMed ID: 33848536
[TBL] [Abstract][Full Text] [Related]
2. The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo.
Panaro BL; Tough IR; Engelstoft MS; Matthews RT; Digby GJ; Møller CL; Svendsen B; Gribble F; Reimann F; Holst JJ; Holst B; Schwartz TW; Cox HM; Cone RD
Cell Metab; 2014 Dec; 20(6):1018-29. PubMed ID: 25453189
[TBL] [Abstract][Full Text] [Related]
3. L-Cell Expression of Melanocortin-4-Receptor Is Marginal in Most of the Small Intestine in Mice and Humans and Direct Stimulation of Small Intestinal Melanocortin-4-Receptors in Mice and Rats Does Not Affect GLP-1 Secretion.
Kuhre RE; Modvig IM; Jepsen SL; Kizilkaya HS; Bæch-Laursen C; Smith CA; Reimann F; Gribble FM; Rosenkilde MM; Holst JJ
Front Endocrinol (Lausanne); 2021; 12():690387. PubMed ID: 34421821
[TBL] [Abstract][Full Text] [Related]
4. Enteroendocrine MC4R and energy balance: linking the long and the short of it.
Manning S; Batterham RL
Cell Metab; 2014 Dec; 20(6):929-31. PubMed ID: 25470541
[TBL] [Abstract][Full Text] [Related]
5. Endogenous PYY and GLP-1 mediate l-glutamine responses in intestinal mucosa.
Joshi S; Tough IR; Cox HM
Br J Pharmacol; 2013 Nov; 170(5):1092-101. PubMed ID: 23992397
[TBL] [Abstract][Full Text] [Related]
6. Role of enteroendocrine L-cells in arginine vasopressin-mediated inhibition of colonic anion secretion.
Pais R; Rievaj J; Meek C; De Costa G; Jayamaha S; Alexander RT; Reimann F; Gribble F
J Physiol; 2016 Sep; 594(17):4865-78. PubMed ID: 27037495
[TBL] [Abstract][Full Text] [Related]
7. Dynamin regulates L cell secretion in human gut.
Sun EW; Matusica D; Wattchow DA; McCluskey A; Robinson PJ; Keating DJ
Mol Cell Endocrinol; 2021 Sep; 535():111398. PubMed ID: 34274446
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin Is Coexpressed, Coreleased, and Acts Together With GLP-1 and PYY in Enteroendocrine Control of Metabolism.
Grunddal KV; Ratner CF; Svendsen B; Sommer F; Engelstoft MS; Madsen AN; Pedersen J; Nøhr MK; Egerod KL; Nawrocki AR; Kowalski T; Howard AD; Poulsen SS; Offermanns S; Bäckhed F; Holst JJ; Holst B; Schwartz TW
Endocrinology; 2016 Jan; 157(1):176-94. PubMed ID: 26469136
[TBL] [Abstract][Full Text] [Related]
9. Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist.
Grunddal KV; Diep TA; Petersen N; Tough IR; Skov LJ; Liu L; Buijink JA; Mende F; Jin C; Jepsen SL; Sørensen LME; Achiam MP; Strandby RB; Bach A; Hartmann B; Frimurer TM; Hjorth SA; Bouvier M; Cox H; Holst B
Mol Metab; 2021 Jul; 49():101207. PubMed ID: 33711555
[TBL] [Abstract][Full Text] [Related]
10. Co-storage and release of insulin-like peptide-5, glucagon-like peptide-1 and peptideYY from murine and human colonic enteroendocrine cells.
Billing LJ; Smith CA; Larraufie P; Goldspink DA; Galvin S; Kay RG; Howe JD; Walker R; Pruna M; Glass L; Pais R; Gribble FM; Reimann F
Mol Metab; 2018 Oct; 16():65-75. PubMed ID: 30104166
[TBL] [Abstract][Full Text] [Related]
11. Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells.
Habib AM; Richards P; Rogers GJ; Reimann F; Gribble FM
Diabetologia; 2013 Jun; 56(6):1413-6. PubMed ID: 23519462
[TBL] [Abstract][Full Text] [Related]
12. Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.
Ullmer C; Alvarez Sanchez R; Sprecher U; Raab S; Mattei P; Dehmlow H; Sewing S; Iglesias A; Beauchamp J; Conde-Knape K
Br J Pharmacol; 2013 Jun; 169(3):671-84. PubMed ID: 23488746
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic neuronal melanocortin-4 receptor modulates serum insulin levels independent of leptin receptor.
Mansour M; White D; Wernette C; Dennis J; Tao YX; Collins R; Parker L; Morrison E
Endocrine; 2010 Feb; 37(1):220-30. PubMed ID: 20963574
[TBL] [Abstract][Full Text] [Related]
14. Intestinal Acyl-CoA synthetase 5 (ACSL5) deficiency potentiates postprandial GLP-1 & PYY secretion, reduces food intake, and protects against diet-induced obesity.
Griffin JD; Zhu Y; Reeves A; Buhman KK; Greenberg AS
Mol Metab; 2024 May; 83():101918. PubMed ID: 38499083
[TBL] [Abstract][Full Text] [Related]
15. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
[TBL] [Abstract][Full Text] [Related]
16. The melanocortin pathway and control of appetite-progress and therapeutic implications.
Baldini G; Phelan KD
J Endocrinol; 2019 Apr; 241(1):R1-R33. PubMed ID: 30812013
[TBL] [Abstract][Full Text] [Related]
17. Differential control of metabolic and cardiovascular functions by melanocortin-4 receptors in proopiomelanocortin neurons.
do Carmo JM; da Silva AA; Rushing JS; Pace B; Hall JE
Am J Physiol Regul Integr Comp Physiol; 2013 Aug; 305(4):R359-68. PubMed ID: 23842677
[TBL] [Abstract][Full Text] [Related]
18. Metformin Triggers PYY Secretion in Human Gut Mucosa.
Sun EW; Martin AM; Wattchow DA; de Fontgalland D; Rabbitt P; Hollington P; Young RL; Keating DJ
J Clin Endocrinol Metab; 2019 Jul; 104(7):2668-2674. PubMed ID: 30759215
[TBL] [Abstract][Full Text] [Related]
19. Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment.
Ayers KL; Glicksberg BS; Garfield AS; Longerich S; White JA; Yang P; Du L; Chittenden TW; Gulcher JR; Roy S; Fiedorek F; Gottesdiener K; Cohen S; North KE; Schadt EE; Li SD; Chen R; Van der Ploeg LHT
J Clin Endocrinol Metab; 2018 Jul; 103(7):2601-2612. PubMed ID: 29726959
[TBL] [Abstract][Full Text] [Related]
20. Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin.
Martin NM; Small CJ; Sajedi A; Patterson M; Ghatei MA; Bloom SR
Int J Obes Relat Metab Disord; 2004 Jul; 28(7):886-93. PubMed ID: 15148507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
